Bosnalijek
Last update: November 13, 2020
Pharmaceuticals
Bosnia and Herzegovina
Its 3 main executives
Create an alert
to follow the executive moves at Bosnalijek.
Most searched biographies at Bosnalijek
- Nedim Uzunović, Chief Executive Officer
- Adnan Handzic, Chief Financial Officer
- Mirela Spahic, Chief Operations Officer
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about Bosnalijek
Dow's nearly 575-point surge highlighted by gains in shares of American Express, UnitedHealth - MarketWatch
Airlines Press for Aid as Deadline to Avert Job Losses Nears - MarketWatch
As Trump continues to press for coronavirus vaccine by Election Day, public health officials vow ‘no cutting corners’ - MarketWatch
Mega-polluter China sets date for curbing emissions, dialing up the pressure on the U.S. - MarketWatch
Facebook gives in to pressure on climate-change myths — including that antifa started deadly wildfires in western states — with new ‘science-based’ hub - MarketWatch
Bosnalijek on Wikipedia, Google News & Yahoo Finance
Bosnalijek on LinkedIn, Twitter & YouTube
Bosnalijek has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Nedim Uzunović 
